Geron other research news

In the Proceedings of the National Academy of Sciences, the Menlo Park, Calif., company and colleagues reported the presence of an immortalizing enzyme in human cancer cells that is absent from all other cells except for the germ cells that make eggs and sperm.

The company is screening for an inhibitor of the enzyme, which could prove to be a specific therapy for cancer without harming other cells. Early results of the screening have been promising, the company told BioCentury, and a compound could be in the clinic in two to three years. ...